MONDAY, Feb. 17, 2025 (HealthDay News) — Millions of Americans have sought help for gambling addiction in the wake of a 2018 U.S. Supreme Court decision that allowed states to legalize sports betting. That’s among the key findings in a new study published Feb. 17 in JAMA Internal Medicine. “Sportsbooks haveContinue Reading
THURSDAY, Feb. 13, 2025 (HealthDay News) — A legal loophole is allowing marijuana ads to slip past regulations and land right in front of kids on social media, a new report shows. Although the federal Controlled Substances Act prohibits advertising the sale or use of marijuana through federal airwaves orContinue Reading
Direct-to-consumer telehealth company advertisement that aired during the Super Bowl failed to mention side effects of the drugsContinue Reading
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced diseaseContinue Reading
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severityContinue Reading
Approval marks the first and only continuous delivery treatment as an alternate to regular eye injectionsContinue Reading
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
TUESDAY, Feb. 4, 2025 (HealthDay News) — Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has found. Nearly half (48%) of people incorrectly think that the benefits of taking low-dose aspirin daily to reduceContinue Reading
TUESDAY, Feb. 4, 2025 (HealthDay News) — Drugs like blood thinners, cholesterol-lowering statins and blood pressure meds can protect the health and extend the lives of people with heart disease. But only if patients take the drugs — and many around the world aren’t, a new study says. Overall, fewerContinue Reading
FRIDAY, Jan. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgeryContinue Reading